Side-by-side comparison of AI visibility scores, market position, and capabilities
Chicago global derivatives exchange (NASDAQ: CME) at $99B market cap; XRP futures launched May 2025 on CFTC commodity approval, expanding crypto suite with Bitcoin/Ethereum/Solana competing with ICE for institutional derivatives volume.
CME Group Inc. is a Chicago, Illinois-based global derivatives exchange operator — publicly traded on NASDAQ (NASDAQ: CME) as an S&P 500 component — operating the world's largest and most diverse derivatives marketplace with a market capitalization of approximately $99 billion and annual revenue exceeding $6 billion, serving customers in approximately 150 countries through nearly 24-hour electronic trading via the CME Globex platform. CME Group operates four major exchanges: the Chicago Mercantile Exchange (CME, founded 1898), Chicago Board of Trade (CBOT, founded 1848), New York Mercantile Exchange (NYMEX), and Commodity Exchange Inc. (COMEX) — offering futures and options contracts across interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, and cryptocurrency. In May 2025, CME Group launched XRP futures following CFTC classification of XRP as a commodity, with first-day trading exceeding $19 million in notional volume across micro (2,500 XRP) and standard (50,000 XRP) contracts — expanding CME's cryptocurrency derivatives suite that already includes Bitcoin, Ethereum, and Solana futures. CME Group employs approximately 3,700 people.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.